DEEJ has continuously received a Wind ESG A rating, with a comprehensive score of 7.73同壁财经·May 30 at 10:02 AM000423-0.79%
China Resources Pharma's subsidiary DEEJ earned 1.739 billion RMB last year, an increase of 11.7%AASTOCKS·Mar 19 at 11:03 AM510660+2.14%159102+2.59%
DEEJ released its performance for the first three quarters, with a net profit attributable to the parent company of 1.274 billion yuan, a year-on-year increase of 10.53%Zhitong·Oct 24, 2025 at 07:19 AM000423-0.79%
China Resources Pharmaceutical: DEEJ's net profit for the first three quarters is 1.277 billion yuan, an increase of 10.77% year-on-yearZhitong·Oct 24, 2025 at 04:12 AM000423-0.79%
Guojin Securities: Terminal demand is gradually recovering, and the prosperity of the pharmaceutical and health industry is expected to riseZhitong·Sep 1, 2025 at 10:40 PM300015-1.21%000999-0.65%
DEEJ: In the first half of 2025, a dividend of 12.7 yuan will be distributed for every 10 shares, with the equity registration date set for September 2, 2025Zhitong·Aug 26, 2025 at 05:10 AM000423-0.79%
DEEJ: Will focus on promoting Southeast Asia export businessZhitong·Aug 24, 2025 at 08:59 AM000423-0.79%
China Resources Pharmaceutical: Dong'e Ejiao's net profit attributable to shareholders in the first half of the year was 818 million yuan, an increase of 10.74% year-on-yearZhitong·Aug 21, 2025 at 07:12 AM000423-0.79%
Main funds have net inflows into 58 stocks for 5 consecutive daysZhitong·Aug 19, 2025 at 09:50 AM002428+10.01%603222+10.03%
DEEJ: The company continues to focus on potential investment targets in the health and wellness sectorZhitong·May 15, 2025 at 07:39 PM000423-0.79%
